The U.S. Food and Drug Administration (FDA) has issued new draft guidance to reduce the use of non-human primates for certain monoclonal antibody (mAb) products. These laboratory-produced antibodies ...
We are calling on the U.S. Congress to fund care for the estimated 200 primates who will no longer be used in research ...